You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ITD

Showing 1 - 25 of 165
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    May 17, 2022

    Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

    Withdrawn
    • Acute Myeloid Leukemia
    • (no location specified)
    May 18, 2022

    Co-existing Mutations on Sorafenib Maintenance Therapy After

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    May 30, 2022

    Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma Trial in Washington

    Recruiting
    • Astroblastoma
    • +3 more
      • Washington, District of Columbia
        Children's National Hospital
      Jan 23, 2023

      Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)

      Terminated
      Has Results
      • Leukemia, Myeloid, Acute
      • Denver, Colorado
      • +4 more
      May 10, 2022

      Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
      • Cincinnati, Ohio
      • +18 more
      Jan 20, 2023

      Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

      Suspended
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 11, 2022

      Obesity, Abdominal Obesity, Metabolic Syndrome Trial in Surabaya (Nur Aisiyah Widjaja)

      Completed
      • Obesity
      • +6 more
      • Nur Aisiyah Widjaja
      • Surabaya, East Java, Indonesia
        Institute of Tropical Disease (ITD) Airlangga University, Campus
      Jan 6, 2023

      Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

      Terminated
      Has Results
      • Acute Myeloid Leukemia
      • Los Angeles, California
      • +7 more
      Mar 14, 2022

      Orthostatic Hypotension Trial in Nashville (Inspiratory Threshold Device (Res-Q-Gard ITD), Sham Inspiratory Threshold Device)

      Withdrawn
      • Orthostatic Hypotension
      • Inspiratory Threshold Device (Res-Q-Gard ITD)
      • Sham Inspiratory Threshold Device
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Nov 13, 2021

      Postural Tachycardia Syndrome, Postural Orthostatic Tachycardia Syndrome Trial in Nashville (Inspiratory Threshold Device

      Active, not recruiting
      • Postural Tachycardia Syndrome
      • Postural Orthostatic Tachycardia Syndrome
      • Inspiratory Threshold Device (Res-Q-Gard ITD)
      • Sham Inspiratory Threshold Device
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Nov 13, 2021

      Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Ponatinib 30 MG
      • Angers, France
      • +13 more
      Aug 4, 2021

      AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

      Unknown status
      • AML
      • FLT3-ITD Mutation
      • Hong Kong, Hong Kong
        The University of Hong Kong
      Dec 9, 2020

      AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

      Recruiting
      • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
      • MRD-triggered arm
      • Prophylactic Arm
      • Heidelberg, BW, Germany
        University Hospital Heidelberg Med5
      Jan 4, 2021

      AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

      Not yet recruiting
      • AML, Adult
      • +4 more
      • Amiens, France
      • +19 more
      Sep 1, 2023

      Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • La Jolla, California
      • +18 more
      Mar 12, 2021

      Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

      Recruiting
      • Acute Myeloid Leukemia
      • Loma Linda, California
      • +36 more
      Feb 1, 2023

      Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)

      Completed
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • Bone Marrow Transplantation
      • +2 more
      • Baltimore, Maryland
      • +1 more
      May 27, 2021

      AML, FLT3-ITD Mutation Trial in Hong Kong (Sorafenib, Omacetaxine Mepesuccinate Injection)

      Completed
      • AML
      • FLT3-ITD Mutation
      • Hong Kong, Hong Kong
        The University of Hong Kong
      Mar 26, 2020

      FLT3-ITD Mutation, AML Trial in Hong Kong (Sorafenib 200mg)

      Completed
      • FLT3-ITD Mutation
      • AML
      • Sorafenib 200mg
      • Hong Kong, Hong Kong
        The University of Hong Kong
      Mar 26, 2020

      Sorafenib to Treat FLT3-ITD AML

      Recruiting
      • Acute Myeloid Leukemia
      • FLT3-ITD Mutation
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Feb 3, 2020